Regius Professor

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

Retrieved on: 
Monday, March 18, 2024

Carmell's Secretome technology delivers 1000+ growth factors, proteins and peptides extracted from allogeneic human platelets in a twelve-month shelf-stable and biologically active formulation.

Key Points: 
  • Carmell's Secretome technology delivers 1000+ growth factors, proteins and peptides extracted from allogeneic human platelets in a twelve-month shelf-stable and biologically active formulation.
  • Carmell’s technology was previously being developed as a BLA and has Phase 2 human clinical data supporting safety and efficacy.
  • In comparison, other aesthetic products feature 1-2 synthetic proteins with sparse evidence of clinical efficacy.
  • Carmell aims to launch a limited-edition product this month followed by 9 other skincare products over the summer 2024.

The Inner Circle Acknowledges, Todd Ochs as a Pinnacle Platinum Healthcare Provider for his contributions to the practice of Pediatrics

Retrieved on: 
Friday, November 17, 2023

CHICAGO, Nov. 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Todd Ochs is acknowledged as a Pinnacle Platinum Healthcare Provider for his contributions to the practice of Pediatrics.

Key Points: 
  • CHICAGO, Nov. 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Todd Ochs is acknowledged as a Pinnacle Platinum Healthcare Provider for his contributions to the practice of Pediatrics.
  • Dr. Ochs began his career in medicine in 1969 at a free clinic in Chicago.
  • In pediatric practice for 39 years, Dr. Ochs is board certified in pediatrics by the American Board of Pediatrics (ABP).
  • Fluent in both English and Spanish, Dr. Ochs notes that his mentors are Dr. Ira Rosenthal and Dr. Andrew Griffin.

The Inner Circle Acknowledges, Joseph P. Calderone as a Top Pinnacle Healthcare Professional for his contributions to the field of Ophthalmology

Retrieved on: 
Friday, September 1, 2023

CRANFORD, N.J., Sept. 1, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joseph P. Calderone is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Ophthalmology.

Key Points: 
  • CRANFORD, N.J., Sept. 1, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joseph P. Calderone is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the field of Ophthalmology.
  • Dr. Calderone began his scholarship at the College of the Holy Cross where he graduated with a Bachelor of Arts degree in Chemistry.
  • The doctor currently works as the Medical and Surgical Director of Better Vision New Jersey (formerly called Cranford Ophthalmology) where he has served since 1987.
  • Dr. Calderone would like to dedicate this honor in loving memory of his father, Joseph P. Calderone, and thanks his wife Heidi, and daughters.

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

Retrieved on: 
Wednesday, August 23, 2023

PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO). Dr. Denlinger—who is currently NCCN's Senior Vice President, Chief Scientific Officer—is being promoted to lead the global guidelines organization following a national search to replace the retiring longtime CEO, Robert W. Carlson, MD.

Key Points: 
  • PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO).
  • Crystal S. Denlinger, MD, FACP, to lead the National Comprehensive Cancer Network (NCCN), a global cancer nonprofit.
  • She will also lead and oversee programs advancing global collaborations, new oncology research, peer-reviewed publication, patient information, and cancer policy.
  • NCCN's recognition and influence relating to national and global cancer care policy also increased dramatically during his tenure."

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

Retrieved on: 
Wednesday, August 23, 2023

PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO). Dr. Denlinger—who is currently NCCN's Senior Vice President, Chief Scientific Officer—is being promoted to lead the global guidelines organization following a national search to replace the retiring longtime CEO, Robert W. Carlson, MD.

Key Points: 
  • PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- Today the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading academic cancer centers—announced Crystal S. Denlinger, MD, FACP, as incoming Chief Executive Officer (CEO).
  • Dr. Denlinger has a long history of global cancer care leadership with NCCN and beyond.
  • She will also lead and oversee programs advancing global collaborations, new oncology research, peer-reviewed publication, patient information, and cancer policy.
  • NCCN's recognition and influence relating to national and global cancer care policy also increased dramatically during his tenure."

On The Field, But Not In Class

Retrieved on: 
Thursday, April 13, 2023

The symposium will unite athletes, coaches, and educators to identify reform strategies to end unintended discrimination against black and other students of color in college athletics.

Key Points: 
  • The symposium will unite athletes, coaches, and educators to identify reform strategies to end unintended discrimination against black and other students of color in college athletics.
  • Moderated by national award-winning journalists, panel experts will focus on male and female scholarship athletes who participate in football and basketball at the highest competitive levels of the National Collegiate Athletic Association (NCAA).
  • These students generate nearly $16 billion in annual revenue for their athletic programs, but only 18.2% is spent on athletic scholarships and 1% percent on medical treatment and benefits for the young athletes.
  • WHAT: Symposium to provide current evidence for prioritizing academic excellence in athletics and strategies for education reform and graduation assurance.

Vaniam Group Expands Clinical Strategy Expertise with Hire of Matthew Burke

Retrieved on: 
Thursday, December 8, 2022

CHICAGO, Dec. 8, 2022 /PRNewswire/ -- Vaniam Group today announced the hiring of Matthew M. Burke, DNP, MBA, RN, APRN-BC, to lead the company's Clinical Strategy & Solutions (CSS) department. As Vice President of Clinical Strategy, Mr. Burke will help Vaniam Group's global biopharmaceutical clients optimize their clinical trials and maximize the potential of their oncology and hematology pipelines.

Key Points: 
  • As Vice President of Clinical Strategy, Mr. Burke will support biopharmaceutical clients with clinical trial optimization, integrated evidence generation, and clinical trial advocacy
    CHICAGO, Dec. 8, 2022 /PRNewswire/ -- Vaniam Group today announced the hiring of Matthew M. Burke, DNP, MBA, RN, APRN-BC, to lead the company's Clinical Strategy & Solutions (CSS) department.
  • As Vice President of Clinical Strategy, Mr. Burke will help Vaniam Group's global biopharmaceutical clients optimize their clinical trials and maximize the potential of their oncology and hematology pipelines.
  • "Matt is the ideal expert to advise our clients on their clinical strategy programs," said Deanna B. van Gestel, Vaniam Group's founder and CEO.
  • Most recently before joining Vaniam Group, Mr. Burke served as Chief of Staff and Head of Clinical Strategy for the Chief Medical Officer at Agenus.

Childhood Lead Poisoning in the Chicago Area: The Latest Evidence and Public Health Approaches

Retrieved on: 
Friday, September 16, 2022

CHICAGO, Sept. 16, 2022 /PRNewswire/ -- The Institute of Medicine of Chicago (IOMC) is pleased to announce its latest webinar 'Childhood Lead Poisoning in the Chicago Area: The Latest Evidence and Public Health Approaches. This program is part of IOMC's programmatic series Public Health, Population Health, and Community Health – Reducing Health Disparities. The webinar will be held on Fri., Sept. 23, 2022 at 12:00 PM CT-1:00 PM CT. The program is open to all and is free. Registration is required, visit this page .

Key Points: 
  • (Our World Data 1.2022)
    CHICAGO, Sept. 16, 2022 /PRNewswire/ -- The Institute of Medicine of Chicago (IOMC) is pleased to announce its latest webinar 'Childhood Lead Poisoning in the Chicago Area: The Latest Evidence and Public Health Approaches.
  • This program is part of IOMC's programmatic series Public Health, Population Health, and Community Health Reducing Health Disparities.The webinar will be held on Fri., Sept. 23, 2022 at 12:00 PM CT-1:00 PM CT.
  • Urban soils contaminated with lead contribute to elevated blood lead levels (BLLs) in young children.
  • In addition, the air and environment may have an elevated lead level contributing to and creating overall lead exposure.

Dale Mullen of Whiteford Taylor Preston Appointed to Virginia Board of Accountancy

Retrieved on: 
Monday, June 6, 2022

Dale G. Mullen, a partner in Whitefords Richmond office, has been appointed to the Virginia Board of Accountancy by Governor Glenn Youngkin.

Key Points: 
  • Dale G. Mullen, a partner in Whitefords Richmond office, has been appointed to the Virginia Board of Accountancy by Governor Glenn Youngkin.
  • I'm thankful for those who will join our Administration, and all who will contribute their time and expertise in service to our commonwealth."
  • Dale Mullen was sworn in by Secretary of the Commonwealth Kay Coles James on March 15.
  • Mr. Mullen brings decades of experience and a deep understanding of the impact of government regulation on licensed professionals and business.

The Luupe Brings On IBM Executive Director Ashley Patterson As Chief Operating Officer

Retrieved on: 
Tuesday, May 10, 2022

Patterson will serve as Chief Operating Officer, where she will help define the company's strategy and further strengthen its foundation and creator network.

Key Points: 
  • Patterson will serve as Chief Operating Officer, where she will help define the company's strategy and further strengthen its foundation and creator network.
  • Patterson is coming from her previous role at IBM, where she served as Executive Director of Marketing and Global Demand Strategy.
  • Here, she rolled out major new operational models that were central to IBM's marketing transformation and its international growth and success.
  • With Patterson onboard, The Luupe will continue to build out its platform, helping brands and professional photographers work together seamlessly.